Connection

Chia Kow to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Chia Kow has written about Angiotensin-Converting Enzyme Inhibitors.
Chia Kow
Connection Strength
0.665
Angiotensin-Converting Enzyme Inhibitors
  1. Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Hypertens Res. 2021 08; 44(8):1042-1045.
    View in: PubMed
    Score: 0.249
  2. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. Am J Cardiovasc Drugs. 2020 Jun; 20(3):217-221.
    View in: PubMed
    Score: 0.233
  3. Do the Meta-Analyses Provide a Clean Bill of Health to the Use of Renin-angiotensin System Inhibitors in Coronavirus Disease 2019 (COVID-19)? Clin Infect Dis. 2021 07 01; 73(1):164-165.
    View in: PubMed
    Score: 0.063
  4. Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic. Expert Rev Cardiovasc Ther. 2021 01; 19(1):99-100.
    View in: PubMed
    Score: 0.060
  5. Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2020 Dec; 20(6):571-590.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.